Deep subcortical infarct burden in relation to apolipoprotein B/AI ratio in patients with intracranial atherosclerotic stenosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, J. -H. | - |
dc.contributor.author | Hong, K. -S. | - |
dc.contributor.author | Lee, J. | - |
dc.contributor.author | Kim, Y. -J. | - |
dc.contributor.author | Song, P. | - |
dc.date.accessioned | 2021-09-06T03:12:28Z | - |
dc.date.available | 2021-09-06T03:12:28Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2013-04 | - |
dc.identifier.issn | 1351-5101 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/103675 | - |
dc.description.abstract | Background and purpose Pre-existing brain infarct (PBI), frequently seen on magnetic resonance imaging and usually silent, is recognized as a risk factor for future stroke. Increased apolipoprotein B (apoB)/apoAI ratio is known to be a risk predictor of ischaemic stroke and is associated with intracranial atherosclerotic stenosis (ICAS). However, little is known about the association of apoB/apoAI ratio with PBI. Methods A total of 522 statin-/fibrate-naive Korean patients, who experienced acute ischaemic stroke, were categorized into three groups: ICAS (n=254), extracranial (n=51), and no cerebral atherosclerotic stenosis (n=217). We explored the association between apoB/apoAI ratio and PBI lesions according to atherosclerosis type (ICAS, ECAS, and NCAS), PBI location (deep subcortical [ds-PBI] versus hemispheric [h-PBI]), and symptomatic PBI (s-PBI) which was relevant to a prior clinical stroke event. Results Pre-existing brain infarct(+) patients showed a higher apoB/apoAI ratio than PBI() patients (0.81 +/- 0.28 vs. 0.72 +/- 0.23, P<0.001). In ICAS group, patients with higher apoB/apoAI ratio quartiles had more PBIs, ds-PBIs, and s-PBIs (P=0.020, P=0.025, and P=0.001, respectively). With multivariable analyses, the highest apoB/apoAI ratio quartile was associated with PBI (OR, 2.56; 95% CI, 1.394.73), ds-PBI (2.48; 1.334.62), and advanced (3) ds-PBIs (2.68; 1.275.63) in ICAS group, but not with h-PBI. s-PBI had a doseresponse relationship with apoB/apoAI ratio quartiles (6.18; 1.3129.13 for the second; 5.34; 1.0626.83 for the third; and 12.17; 2.5059.19 for the fourth quartile), when referenced to the first quartile. Conclusion ApoB/apoAI ratio is associated with asymptomatic deep subcortical ischaemic burden as well as with symptomatic lesion in patients with ICAS. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.subject | MIDDLE CEREBRAL-ARTERY | - |
dc.subject | SILENT BRAIN INFARCTS | - |
dc.subject | ISCHEMIC-STROKE | - |
dc.subject | A-I | - |
dc.subject | METABOLIC SYNDROME | - |
dc.subject | VASCULAR EVENTS | - |
dc.subject | RISK | - |
dc.subject | DISEASE | - |
dc.subject | PROGRESSION | - |
dc.subject | MANAGEMENT | - |
dc.title | Deep subcortical infarct burden in relation to apolipoprotein B/AI ratio in patients with intracranial atherosclerotic stenosis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, J. | - |
dc.identifier.doi | 10.1111/ene.12021 | - |
dc.identifier.scopusid | 2-s2.0-84875036750 | - |
dc.identifier.wosid | 000316258800018 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF NEUROLOGY, v.20, no.4, pp.671 - 680 | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF NEUROLOGY | - |
dc.citation.title | EUROPEAN JOURNAL OF NEUROLOGY | - |
dc.citation.volume | 20 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 671 | - |
dc.citation.endPage | 680 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | MIDDLE CEREBRAL-ARTERY | - |
dc.subject.keywordPlus | SILENT BRAIN INFARCTS | - |
dc.subject.keywordPlus | ISCHEMIC-STROKE | - |
dc.subject.keywordPlus | A-I | - |
dc.subject.keywordPlus | METABOLIC SYNDROME | - |
dc.subject.keywordPlus | VASCULAR EVENTS | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordAuthor | apolipoprotein AI | - |
dc.subject.keywordAuthor | apolipoprotein B | - |
dc.subject.keywordAuthor | atherosclerosis | - |
dc.subject.keywordAuthor | brain infarction | - |
dc.subject.keywordAuthor | intracranial | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.